ArticleJournal of orthopaedics2025
Effect of hyperbaric oxygen therapy (HBO) on osteoblasts of elderly patients on calcification and osteoprotegerin.
Article in Journal of orthopaedics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Adjunctive Therapies in Long-Bone Distraction Osteogenesis: Clinical Evidence for Biophysical and Biologic Treatment Strategies.Journal of clinical medicine · 2026Review
- Hyperbaric oxygen protects against periodontal bone loss by modulating inflammation and bone remodeling via RANKL/OPG expression in ligature-induced periodontitis.International journal of medical sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Osteoporosis stands as one of the most prevalent bone diseases worldwide. This study aims to explore the effects of Hyperbaric Oxygen (HBO) therapy and substances that reduce reactive oxygen species (ROS), such as antioxidants, on osteogenic differentiation and key osteoporosis-related parameters in osteoblasts derived from elderly patients requiring hip arthroplasty. Methods: An in vitro study was conducted using osteoblasts isolated from the femoral heads of 22 patients (78.3 % female) with a mean age of 73 years. Bone mineral density (BMD) was assessed through dual-energy X-ray absorptiometry (DXA), classifying patients into three groups: normal (age-appropriate) BMD (n = 8), osteopenia (n = 6), and osteoporosis (n = 8). Osteogenic differentiation was induced, and HBO therapy was administered over a period of 21 days. Additionally, osteoblasts were treated with catalase. Parameters related to osteogenic differentiation and osteoporosis were evaluated. Results: HBO therapy prompted osteogenic differentiation in all three experimental groups after 21 days, with statistically significant findings (p = 0.0125) in osteoblasts with age-appropriate bone density. Furthermore, the activity of alkaline phosphatase (ALP), an enzyme indicative of bone synthesis, demonstrated significant increases across all groups following HBO treatment (normal BMD and osteoporotic cells: p = 0.04; osteopenic cells: p = 0.006). Conclusions: These findings suggest that HBO therapy holds potential as an adjunctive or investigational treatment for elderly patients to enhance bone density or facilitate bone healing post-fracture, especially in those with normal or osteopenic bone density. This approach could potentially influence clinical practices in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.